Trinseo (TSE) Q4 2024 earnings summary

Executive summary

• Q4 2024 net loss was $118 million and EPS was $(3.33), including $28 million in pre-tax restructuring charges for the Stade, Germany plant decommissioning, with a $147 million improvement from prior year due to lower tax provisions and restructuring charges.

• Adjusted EBITDA for Q4 2024 was $26 million, up $6 million year-over-year, with all core segments except Americas Styrenics showing improvement.

• Q4 cash from operations was $85 million, with free cash flow of $64 million, a $67 million improvement both sequentially and year-over-year, driven by lower working capital needs.

• Closed refinancing in January 2025, extending nearest-term debt maturity to 2028 and increasing pro-forma liquidity to $492 million.

• Achieved significant safety milestones, with 19 facilities and R&D teams earning Triple Zero Awards for zero injuries, spills, and process safety events in 2024.

Financial highlights

• Q4 2024 net sales were $821 million, down 2% year-over-year due to a 6% volume decline, partially offset by 4% price and 1% FX gains.

• Q4 2024 Adjusted EBITDA was $26 million, $6 million above prior year, with improved results in all core segments except Americas Styrenics.

• Americas Styrenics equity affiliate income was $23 million below prior year, mainly from a $15 million unfavorable timing impact.

• Sales of recycled-content products grew 47% year-over-year, now representing 4% of total company variable margin.

• Q4 2024 gross profit was $56 million, up from $20 million in Q4 2023.

Outlook and guidance

• Q1 2025 net loss expected between $40 million and $60 million; Adjusted EBITDA forecasted at $60–$80 million, including a one-time $26 million contribution from a polycarbonate technology license agreement.

• Q1 2025 expected to be sequentially better than Q4, but volumes still lower year-over-year due to ongoing weakness in key end markets.

• Full-year 2025 profitability improvement anticipated from restructuring, normalized Americas Styrenics earnings, and new business wins, but no material change in demand environment expected.

• Full-year guidance not provided due to market uncertainty, but positive earnings momentum expected from cost reductions, licensing, and normalized joint venture contributions.